Microsoft has ended support for its pre-IE11 browsers as of January 2016 and will be discontinuing IE11 support in August 2021.

If you are seeing this message, you are viewing the site on one of these unsupported browsers. We only support the recent versions of major browsers such as Chrome, Firefox, Safari, and Edge.

Thank you.

(click to close and continue using this browser)

Sign InDues Join Donate Privacy Contact Search
Home News APCR Response to Speaker Pelosi's Proposed Medicare Changes


APCR Response to Speaker Pelosi's Proposed Medicare Changes

posted: September 19, 2019

House Speaker Nancy Pelosi released a plan today on changes to the way the U.S. values and reimburses prescription drugs, including in the Medicare program, which will have significant impacts on clinical research in the future. The plan would enable direct price negotiation on up to 250 drugs, implement new liabilities in the Medicare program, new price controls, and the hammer of a 65-95% new tax. These policies will impact investment in clinical research and innovation may suffer as a result. The Academy of Physicians in Clinical Research (APCR) released the following statement regarding the proposed changes.

Read the Full Letter